Home LiteratureArticle Details
PMID: 9169486 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains.

The Journal of clinical investigation ·Vol. 99 ·No. 11 ·1997-06-01 ·Pages 2574-80

Lukomski S, Sreevatsan S, Amberg C, Reichardt W, Woischnik M, Podbielski A, Musser JM

Abstract

Cysteine proteases have been implicated as important virulence factors in a wide range of prokaryotic and eukaryotic pathogens, but little direct evidence has been presented to support this notion. Virtually all strains of the human bacterial pathogen Streptococcus pyogenes express a highly conserved extracellular cysteine protease known as streptococcal pyrogenic exotoxin B (SpeB). Two sets of isogenic strains deficient in SpeB cysteine protease activity were constructed by integrational mutagenesis using nonreplicating recombinant plasmids containing a truncated segment of the speB gene. Immunoblot analyses and enzyme assays confirmed that the mutant derivatives were deficient in expression of enzymatically active SpeB cysteine protease. To test the hypothesis that the cysteine protease participates in host mortality, we assessed the ability of serotype M3 and M49 wild-type strains and isogenic protease-negative mutants to cause death in outbred mice after intraperitoneal inoculation. Compared to wild-type parental organisms, the serotype M3 speB mutant lost virtually all ability to cause mouse death (P < 0.00001), and similarly, the virulence of the M49 mutant was detrimentally altered (P < 0.005). The data unambiguously demonstrate that the streptococcal enzyme is a virulence factor, and thereby provide additional evidence that microbial cysteine proteases are critical in host-pathogen interactions.

MeSH Terms
Animals Cysteine Endopeptidases/genetics,metabolism Humans Male Mice Mutagenesis Mutation Plasmids Streptococcal Infections/enzymology,mortality Streptococcus pyogenes/enzymology,pathogenicity Virulence/genetics
Chemicals
Cysteine Endopeptidases
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Lukomski S
Section of Molecular Pathobiology, Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, USA.
Sreevatsan S
Amberg C
Reichardt W
Woischnik M
Podbielski A
Musser J M
References (46)
46 references, click to expand
  1. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis.
    J Infect Dis. 1992 Aug;166(2):374-82 PMID: 1634809
  2. Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes.
    Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7676-80 PMID: 7689226
  3. Extracellular antigens in steady-state cultures of the hemolytic Streptococcus: production of proteinase at low pH.
    J Bacteriol. 1958 Aug;76(2):142-51 PMID: 13563408
  4. Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers.
    Clin Infect Dis. 1996 Mar;22(3):490-5 PMID: 8852968
  5. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression.
    Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2668-72 PMID: 1672766
  6. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome.
    Infect Immun. 1993 Aug;61(8):3369-74 PMID: 8335368
  7. Fluorescein isothiocyanate-labeled casein assay for proteolytic enzymes.
    Anal Biochem. 1984 Nov 15;143(1):30-4 PMID: 6442109
  8. What is the size of the group A streptococcal vir regulon? The Mga regulator affects expression of secreted and surface virulence factors.
    Med Microbiol Immunol. 1996 Nov;185(3):171-81 PMID: 9007823
  9. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children.
    JAMA. 1997 Jan 1;277(1):38-43 PMID: 8980208
  10. Substitution of cysteine 192 in a highly conserved Streptococcus pyogenes extracellular cysteine protease (interleukin 1beta convertase) alters proteolytic activity and ablates zymogen processing.
    Infect Immun. 1996 Jun;64(6):1913-7 PMID: 8675287
  11. Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G.
    Infect Immun. 1996 Dec;64(12):5395-8 PMID: 8945593
  12. Horizontal gene transfer among group A streptococci: implications for pathogenesis and epidemiology.
    Trends Microbiol. 1996 Nov;4(11):436-43 PMID: 8950813
  13. Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice.
    Immunity. 1995 Jul;3(1):9-19 PMID: 7621081
  14. Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor.
    Zentralbl Bakteriol Mikrobiol Hyg A. 1983 Sep;255(2-3):221-33 PMID: 6359775
  15. Different forms of streptolysin O produced by Streptococcus pyogenes and by Escherichia coli expressing recombinant toxin: cleavage by streptococcal cysteine protease.
    Infect Immun. 1995 Jul;63(7):2776-9 PMID: 7790099
  16. The group A streptococcal virR49 gene controls expression of four structural vir regulon genes.
    Infect Immun. 1995 Jan;63(1):9-20 PMID: 7806389
  17. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin.
    Microb Pathog. 1993 Nov;15(5):327-46 PMID: 7516997
  18. Role of Porphyromonas gingivalis protease activity in colonization of oral surfaces.
    Infect Immun. 1996 Oct;64(10):4067-73 PMID: 8926070
  19. Inactivation of the streptokinase gene prevents Streptococcus equisimilis H46A from acquiring cell-associated plasmin activity in the presence of plasminogen.
    FEMS Microbiol Lett. 1994 Feb 1;116(1):107-12 PMID: 8132150
  20. Frequency of the erythrogenic toxin B and C genes (speB and speC) among clinical isolates of group A streptococci.
    Infect Immun. 1991 Jan;59(1):211-5 PMID: 1987034
  21. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock.
    Cell. 1995 Feb 10;80(3):401-11 PMID: 7859282
  22. Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor.
    Nature. 1989 Jan 26;337(6205):385-6 PMID: 2643059
  23. Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci.
    Mol Microbiol. 1994 Nov;14(4):619-31 PMID: 7891551
  24. Myocardial necrosis produced in animals by means of crystalline streptococcal proteinase.
    J Exp Med. 1954 May 1;99(5):495-503 PMID: 13163324
  25. Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci.
    Microb Pathog. 1994 Jun;16(6):443-50 PMID: 7830531
  26. Molecular characterization of group A streptococcal (GAS) oligopeptide permease (opp) and its effect on cysteine protease production.
    Mol Microbiol. 1996 Sep;21(5):1087-99 PMID: 8885277
  27. Inactivation of the streptococcal erythrogenic toxin B gene (speB) in Streptococcus pyogenes.
    Infect Immun. 1993 Sep;61(9):3719-23 PMID: 8359893
  28. Growth characteristics of group A streptococci in a new chemically defined medium.
    Infect Immun. 1980 Feb;27(2):444-8 PMID: 6991416
  29. Virulence of a Porphyromonas gingivalis W83 mutant defective in the prtH gene.
    Infect Immun. 1995 Apr;63(4):1521-8 PMID: 7890419
  30. Generation and characterization of urokinase receptor-deficient mice.
    J Clin Invest. 1996 Feb 1;97(3):870-8 PMID: 8609247
  31. Models of T cell anergy: is there a common molecular mechanism?
    J Exp Med. 1996 Jul 1;184(1):1-8 PMID: 8691122
  32. Porphyromonas gingivalis: a proteinase/gene accounting audit.
    Trends Microbiol. 1995 Nov;3(11):430-4 PMID: 8574516
  33. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings.
    Clin Infect Dis. 1992 Aug;15(2):277-84 PMID: 1520763
  34. The determination of streptococcal antiproteinase titers in sera of patients with rheumatic fever and streptococcal infection.
    J Immunol. 1958 Nov;81(5):396-403 PMID: 13598921
  35. The proteases and pathogenicity of parasitic protozoa.
    Annu Rev Microbiol. 1993;47:821-53 PMID: 8257117
  36. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin).
    J Infect Dis. 1993 Feb;167(2):337-46 PMID: 8093623
  37. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989.
    J Infect Dis. 1992 Jul;166(1):31-7 PMID: 1607705
  38. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci.
    Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8317-21 PMID: 1656437
  39. Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor.
    J Bacteriol. 1990 Aug;172(8):4536-42 PMID: 2198264
  40. Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease.
    Infect Immun. 1996 Nov;64(11):4744-50 PMID: 8890235
  41. Streptococcal cysteine protease augments lung injury induced by products of group A streptococci.
    Infect Immun. 1996 Mar;64(3):870-7 PMID: 8641794
  42. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease.
    Infect Immun. 1995 Mar;63(3):994-1003 PMID: 7868273
  43. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface.
    J Biol Chem. 1994 Dec 2;269(48):30682-7 PMID: 7982988
  44. Novel streptococcal-integration shuttle vectors for gene cloning and inactivation.
    Gene. 1992 Oct 12;120(1):105-10 PMID: 1327968
  45. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes.
    J Exp Med. 1991 Nov 1;174(5):1271-4 PMID: 1940804
  46. Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins.
    J Biol Chem. 1995 Apr 28;270(17):9862-7 PMID: 7730368
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1997-06-01
Pages
2574-80
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC508102
Subset
IM
Grants
NIAID NIH HHS · AI-33119 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com